powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1710203815
Amrew Al-Ahmad
M.D.
Pulmonary Disease
Houston,
TX
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
QUALITY · MIPS · 2024
Final MIPS score
94.0
Quality
80.6
Cost
79.5
Improvement activities
40.0
Promoting interop.
99.0
Payment adjustment
0.80%
Individual
PRESCRIBING · PART D · 2024
Total Rx claims
702
Beneficiaries
—
Total drug cost
$260K
Distinct drugs
18
Brand share
70.4%
Top prescribed drugs
Fluticasone/Umeclidin/Vilanter
180 claims
Albuterol Sulfate
148 claims
Prednisone
55 claims
Fluticasone Propionate
38 claims
Fluticasone Propion/Salmeterol
27 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$633
Payment records
29
By payment type
Food and Beverage
$633
Top paying entities
Food and Beverage
$633
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,995
Unique beneficiaries
—
Total services
2,993
Distinct HCPCS
18
Medicare payment
$203K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 664 Pulmonary Disease providers in TX — top quintile (cohort median 1,111).
